Skip to main content
OpenTrials

Clinical trial condition

Lentivirus Infections

Explore clinical trials studying Lentivirus Infections. Study availability and eligibility vary by location and protocol.

5,643 public trials 304 recruiting studies
Refine in advanced search Browse all conditions

Lentivirus Infections trial results

Completed

IMPAACT 1077HS: Examining Benefits of HAART Continuation in Postpartum Women

NCT00955968

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +12 more
Locations
  • University of Southern California MCA Center (5048) Alhambra, California, United States
  • David Geffen School of Medicine at UCLA (5112) Los Angeles, California, United States
  • UCSD Mother-Child-Adolescent HIV Program (4601) San Diego, California, United States
  • Harbor (UCLA) Medical Center (5045) Torrance, California, United States
View all 50 locations
View Trial Details
Completed

Open-Label, 48-Week Extension Study of Elvucitabine in Combination With Background Antiretroviral Therapy (ART) for Participants Who Have Completed Study ACH443-014A

NCT00380159

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations
  • Clinical Trial Site Atlanta, Georgia, United States
  • Clinical Trial Site Cincinnati, Ohio, United States
  • Clinical Trial Site Santo Domingo, Dominican Republic
  • Clinical Trial Site Berlin, Germany
View Trial Details
Completed

Safety and Drug Detection Study of Dapivirine Vaginal Ring and Oral TRUVADA® in Breastfeeding Mother-Infant Pairs

NCT04140266

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Blantyre CRS (Johns Hopkins Research Project/College of Medicine) Blantyre, Malawi
  • Wits RHI Shandukani Research Centre CRS Johannesburg, Gauteng, South Africa
  • MU-JHU Research Collaboration (MUJHU CARE LTD) CRS Kampala, Uganda
  • Zengeza CRS Chitungwiza, Mashonaland East Province, Zimbabwe
View Trial Details
Completed

Like Father Like Son

NCT04119414

Conditions
Behavior, Blood-Borne Infections, Communicable Diseases, +15 more
Locations
  • Lusaka Province Community Health Clinics Lusaka, Zambia
View Trial Details
Completed

Safety, Tolerability and Immunogenicity of MVA.HTI and ChAdOx1.HTI With Vesatolimod in HIV-1 Positive Patients

NCT04364035

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations
  • IrsiCaixa AIDS Research Institute, Hospital Universitari Germans Trias i Pujol Badalona, Barcelona, Spain
  • Hospital Universitario de Bellvitge L'Hospitalet de Llobregat, Barcelona, Spain
  • Hospital de la Santa Creu i Sant Pau Barcelona, Spain
  • Hospital Clinic de Barcelona Barcelona, Spain
View Trial Details
Completed

Switch Study to Evaluate Dolutegravir Plus Lamivudine in Virologically Suppressed Human Immunodeficiency Virus Type 1 Positive Adults (TANGO)

NCT03446573

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +13 more
Locations
  • GSK Investigational Site Phoenix, Arizona, United States
  • GSK Investigational Site Scottsdale, Arizona, United States
  • GSK Investigational Site Bakersfield, California, United States
  • GSK Investigational Site Beverly Hills, California, United States
View all 133 locations
View Trial Details

Related conditions